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Abstract
Background We evaluated if the intragastric balloon (IGB) treatment leads to the increase in physical activity (PA) and whether
they are related to cognitive improvements.
Methods Fourteen morbidly obese patients (151 ± 24 kg, BMI = 51.8 ± 6.5, 107 ± 26% excess weight, 43.3 ± 10.6 years)
underwent 6-day-long, uninterrupted evaluations of PA 1 month before IGB insertion and 1 month after its removal.
Results Active energy expenditure and physical activity duration increased by more than 80% (p < 0.001) whereas the number of
steps per day by 20% (p = 0.016). There was a pattern of relationships between cognitive improvements and increases in PA
(p < 0.05). In particular, workingmemory improvements correlatedwith the increase in time spent on light physical activities (r =
0.673, p = 0.004).
Conclusion The relationships suggest that an increase in physical activity mediates cognitive improvements in bariatric patients.
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Introduction
Endoscopic insertion of the intragastric balloon (IGB) is a
minimally invasive procedure leading to premature satiation,
prolonged satiety, and influences the hormone levels regulat-
ing energy balance [1–7] The weight reductions induced by
IGB are retained by a relatively low number of patients over
longer periods after its removal [1, 8–10]. As physical activity
(PA) plays an important role in promoting long-term weight
maintenance [11], we have evaluated changes in PA accom-
panying IGB treatment.
Weight loss is associated with improvement in cognitive
functions among overweight, obese [12], and morbidly obese
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in verbal short-term memory, visual short-term memory, and
sustained and divided attention among patients treated with
IGB [16]. However, it is well established that increases in PA
lead to cognitive improvements, especially in executive func-
tions and short-term memory [17, 18]. Such effects were also
described in obese, but not bariatric, populations [19]. We
hypothesized that an increase in PA following IGB treatment
will be associated with improvements in cognitive perfor-
mance on tests of visual short-term memory, sustained and
divided attention, and working memory.
Materials and Methods
Study Participants
Thirty patients were enrolled in a neuroimaging study evalu-
ating functional and structural brain changes accompanying
IGB-induced weight loss [16, 20–22]. They were consecutive
patients qualified for 650-ml saline-filled IGB treatment last-
ing 6 months (in accordance with the manufacturer’s recom-
mendations) between April 2015 and December 2016, who
did not have contraindications for magnetic resonance. The
study was performed twice: 1 month before IGB insertion
and 1 month after its removal. This timing was adjusted to
minimize the adverse effects of the IGB procedures on the
measures of interest. Each study included MRI in the morning
hours (results described in [20]), followed by cognitive test-
ing. Before discharging, devices evaluating physical activity
were attached to the patients’ forearms at every visit (Fig. 1).
Although these devices had been earlier tested on soldiers
during military training, they did not adhere to the skin of
the patients and detached. This problem was later fixed by
the manufacturer; therefore, we only have data on 14morbidly
obese patients (43.3 ± 10.6 years, 7 females, 8 with comorbid
type 2 diabetes, 151 ± 24 kg, BMI = 51.8 ± 6.5, %EW= 107
± 26% excess body weight).
One patient had a gastric ulcer hemorrhage caused by tak-
ing aspirin against medical advice. This led to premature IGB
removal 1 month prior to the scheduled time [23]. However,
his PA measures were within the range of results of other
patients taking part in the study. Detailed information on the
participants is provided in Table 1.
Ten patients met criteria for hypertension when their blood
pressure was measured, four had dyslipidemia, seven had a
fatty liver diagnosis, and three were cigarette smokers. Eight
patients had a history of gastritis, six wereHelicobacter pylori
positive, one had diabetic polyneuropathy and diabetic reti-
nopathy, and two had obstructive sleep apnea. The detailed
demographic andmedical information on the subjects 1 month
prior to entry into the treatment is provided in Table 1.
All participants gave written informed consent to all pro-
cedures prior to the study. All procedures had been approved
by the Institutional Review Board of the (BLINDED) and
have been performed in accordance with the ethical standards
as laid down in the 1964 Declaration of Helsinki and its later
amendments or comparable ethical standards.
Measuring Methodology
PA was assessed using Metria IH1 devices (Vandrico, USA,
Fig. 1.) that automatically evaluate physical activity duration
and active energy expenditure (AEE) for at least 5 days (up to
Fig. 1 Metria IH1 device that continuously measures physical activity
over 1 week
Table 1 Demographics and medical information. OSA = obstructive
sleep apnea
Parameter
Age [years] 43.3 ± 10.6
Type 2 diabetes mellitus [n] 8
Females [n] 7
Weight [kg] 151 ± 24
BMI [kg/m2] 51.8 ± 6.5
%EW [%] 107 ± 26
Hypertension [n] 10
Dyslipidemia [n] 4
Fatty liver [n] 7
Cigarette smokers [n] 3
Gastritis [n] 8
H. pylori positive [n] 6
OSA [n] 2
Diabetic microangiopathy [n] 1
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1 week). This device provided continuous monitoring of the
parameters of interest. Any detachment from the arm by the
patient would be recorded and such data would be discarded.
AEE was defined as tasks at more than 1.5 METs (1 MET =
energy expenditure of a person sitting quietly). Average pa-
rameters describing physical activity (see Table 2) were cal-
culated only over the days when the device was attached to the
skin of the patient for the entire 24 h. The device was attached
to the skin in the vast majority of the patients for 6 days.
The patients also underwent tests of visual short-term
memory (Benton Visual Retention Test, [24]), visual search
and sustained and divided attention (Color Trail Test, CTT-1,
CTT-2, (BLINDED) normalization [25]), auditory attention,
and verbal working memory (Digit Span from WAIS-R,
(BLINDED) version revised and renormalized in 2004).
Parallel versions of the tests were utilized in random order.
Statistical Analyses
The changes in individual parameters were evaluated using
paired t tests. Percent changes in the measures were provided.
Relationships between measures and their changes were eval-
uated with the Pearson product-moment correlation coeffi-
cient; the results were visually checked for outliers. All corre-
lational tests were conducted with R version 3.4.3 (R Core
Team, 2017 R: A language and environment for statistical
computing. R Foundation for Statistical Computing, Vienna,
Austria. URL https://www.R-project.org/). Given the small
sample size, we considered correlations at significance level
of 0.01 (or less) statistically significant.
Results
Changes in Physical Activity
The detailed information on parameters describing PA is pro-
vided in Table 2. Over the entire treatment (between 1 month
IGB before insertion and 1 month past its removal), there was
a 490 ± 440 kcal (87%) increase in active energy expenditure
(p = 0.001), 110 ± 80 min (109%) increase in physical activity
duration (p < 0.001), 1100 ± 1700 (20%) increase in number
of steps per day (p = 0.016), 0.10 ± 0.14 (10.2%) increase in
average MET (p = 0.008), 46 ± 71 min (35%) increase in light
activities (p = 0.015), and 14 ± 19 min (86%) increase in mod-
erate activities (p = 0.007), accompanied by 65 ± 79 min
(5.1%) decrease in time spent on sedentary activities (p =
0.005). These changes were overlaid on a 7% (p = 0.03) de-
crease in total energy expenditure, driven mainly by the de-
crease in resting metabolic rate that is generally observed [22].
Correlations
Over the entire treatment, between insertion and removal of
IGB, improvements in working memory were related to in-
creases in the duration of light physical activity (r = 0.673, p =
0.004, Fig. 2) and tended to correlate with the increase in the
number of steps (r = 0.514, p = 0.03). These improvements
also tended to be related to the shortening of sedentary activ-
ities (r = − 0.591, p = 0.03). A decrease in the total number of
errors on the Benton test tended to be related to an increase in
AEE (r = − 0.600, p = 0.012) and increases in MET (r = −
0.476, p = 0.043). Decreases in execution time on Color
Trail Test (CTT-1) tended to be related to decreases in body
mass, BMI, and %EW (r > 0.52, p < 0.042). Interestingly, no
changes in PA correlated with changes in body mass, BMI,
and %EW (|r| < 0.38, p > 0.26).
Table 2 Measures of physical activity before and after IGB insertion
Month before insertion Month after insertion
Total EE [kcal] 3630 ± 700* 3370 ± 710
Active EE [kcal] 560 ± 370* 1040 ± 550
PA Duration [min] 102 ± 70* 212 ± 96
Steps [n] 5520 ± 1880* 6600 ± 1820
Lying down [min] 470 ± 150 480 ± 130
Sleep [min] 340 ± 110 370 ± 120
Mean MET 1.01 ± 0.08* 1.11 ± 0.08
Sedentary [min] 1290 ± 70 1220 ± 100
Light [min] 130 ± 60* 180 ± 80
Moderate [min] 16.6 ± 16.6* 30.9 ± 30.2
Vigorous [min] 0.0 ± 0.0 3.6 ± 12.9
The grades of physical activity were defined as follow: sedentary (<
1.5METs), light (1.5–3.0METs), moderate (3.0–6.0METs), and vigorous
(6.0–9.0 METs). Two participants had activity at vigorous level after IGB
removal. No participant had ever activity at very vigorous level (> 9.0
METs). Total EE = total energy expenditure (includes resting metabolic
rate). PA = physical activity
*Indicates statistically significant change
Fig. 2 Improvements in working memory scores as a function of
lengthening of light physical activity. Please not that negative
improvements represent cases, where the patients remembered less
items after IGB removal that before
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Discussion
We have observed weight reduction in a group of fourteen
morbidly obese patients treated with an intragastric balloon
between 1 month prior to IGB insertion and 1-month post-
IGB removal. Substantial increases in physical activity were
recorded. In particular, increases in energy expenditure and
PA duration were accompanied by a reduction in time spent
on sedentary activities. These changes were related to im-
provements in working memory.
The observed weight reduction in our study was compara-
ble to previous reports [3, 4, 6]. Slightly larger weight reduc-
tion in our study (about 23 kg vs. 17–18 kg) [3, 4] or 11.7 kg
[26] could have resulted from the longer, 8-month interval in
our study, as compared to 6 months in studies measuring dif-
ferences between weight on the day of IGB insertion and IGB
removal. Conversely, when the interval was longer than in our
study, some patients started to regain weight; thus, the report-
ed reductions were also slightly lower than in our study (see
[6]).
The patients increased the intensity of their physical activ-
ity, somewhat in contrast to earlier studies that did not dem-
onstrate any significant increases in PA following bariatric
surgery [27, 28]. In contrast to the earlier studies, our partic-
ipants had continuous PA measurement over 6 days, whereas,
e.g., in other studies, the measurement was carried out only
several hours a day, e.g., more than 10 h a day for 4 days [28].
Self-assessment questionnaires were not used in our study, as
patients tend to overestimate their physical activity changes
[27, 28]. The large increases in PA in our cohort likely reflect
the very low level of PA at the baseline. Despite the improve-
ments, the WHO-recommended level of 10,000 steps/day was
not reached. Long-term changes in PA after IGB removal and
their relationship to bodyweight need to be evaluated, given
their potential influence on long-term weight maintenance in
patients treated with IGB. Therefore, PA changes and their
effects on long-term weight reduction and weight mainte-
nance should be evaluated. Furthermore, the use of IGB reg-
istered for 12 months use should be evaluated in future
studies.
Conclusions
To our knowledge, this is the first study to evaluate correla-
tions between increases in physical activity and cognitive im-
provements in bariatric populations. Intragastric balloon ther-
apy is associated with substantial increases in PA. They cor-
related with improvements of working memory and showed
tendencies with improvements on other tests. Further studies
are needed to evaluate the long-term effects of PA in the long-
term maintenance of reduced body weight.
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